arrow
F

Francisco Jaime Bezerra Mendonça

state university of paraiba
H指数:32
被引数:2,825

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Generative AI-Driven Discovery and Experimental Validation of a Novel EGFR Inhibitor for the Treatment of Pancreatic Cancer

生成式AI驱动的胰腺癌治疗用新型EGFR抑制剂的发现与实验验证

2026-09-280
OAAI
Dual antileishmanial and immunoregulatory activities of synthetic chalcones against Leishmania braziliensis

合成的查尔酮对巴西利什曼原虫具有双重抗利什曼作用和免疫调节活性

2026-09-140
OAAI
In Vitro and In Silico Evaluation of the Potentiating Effect of Thiadiazine Derivatives Against Multidrug-Resistant (MDR) Bacterial Strains

体外和计算机模拟评价噻二嗪衍生物对多药耐药(MDR)细菌菌株的增强作用

2026-08-160
OAAI
Guanidines: Privileged Scaffolds Against Neglected Tropical Diseases: A Review

胍类:抗热带病药物中的 privileged Scaffolds:综述

2026-05-170
OA
Advances in leishmaniasis therapy: preparation; characterization and in vitro evaluation of poly (lactic acid) polymeric nanoparticles with the drug candidate SB-83

利什曼病治疗进展:药物候选物SB-83的聚乳酸聚合物纳米粒子的制备、表征及体外评价

2025-12-190
PRE
Drug design and synthesis of new N-substituted-thienopyridine based on 2-aminothiophene derivatives as antileishmanial agents

基于2-氨基噻吩衍生物的新型N-取代-噻吩并吡啶的药物设计与合成,作为抗利什曼原虫药物。

2025-10-310
PRE
Modifying Antibiotic Activity of Synthetic Thiadiazine Analogs Against MDR Bacteria and ADMET Analysis
2025-10-010
OAAI
2-Aminothiophene derivatives reduce resistance to fluoroquinolones in Staphylococcus aureus strains which overexpress NorA and MepA efflux pumps

2-氨基噻吩衍生物降低过表达NorA和MepA外排泵的金黄色葡萄球菌菌株对氟喹诺酮类药物的耐药性

2025-09-200
PRE
Host-Mediated Antimicrobial Effects and NLRP3 Inflammasome Modulation by Caulerpin and Its Derivatives in Macrophage Models of Mycobacterial Infections

宿主介导的抗微生物效应及NLRP3炎性小体调控:在分枝杆菌感染巨噬细胞模型中由Caulerpin及其衍生物引起

2025-03-010
OA
Evaluation of the Efflux Pump Inhibition Activity of Thiadiazine-Derived Compounds Against the Staphylococcus aureus 1199B Strain
2025-02-250
OAAI
Preclinical Evaluation of Selene-Ethylenelacticamides in Tuberculosis: Effects Against Active, Dormant, and Resistant Mycobacterium Tuberculosis and In Vitro Toxicity Investigation
2025-02-110
OAAI
Nanomolar activity of coumarin-3-thiosemicarbazones targeting Trypanosoma cruzi cruzain and the T. brucei cathepsin L-like protease

克氏锥虫和布氏组织蛋白酶L样蛋白酶靶向coumarin-3-thiosemicarbazones的纳摩尔活性

2025-02-010
PRE
Evaluation of SB-83, a 2-amino-thiophene derivative, against Leishmania species that cause visceral leishmaniasis

评价SB-83(一种2-氨基噻吩衍生物)对引起内脏利什曼病的利什曼原虫种的抗性

2025-02-010
PRE
Evaluation of the Anti-Mycobacterial and Anti-Inflammatory Activities of the New Cardiotonic Steroid γ-Benzylidene Digoxin-15 in Macrophage Models of Infection
2025-01-251
OAAI
2-Aminothiophene Derivatives-New Drug Candidates Against Leishmaniasis: Drug Design, Synthesis, Pharmacomodulation, and Antileishmanial Activity
2025-01-170
OAAI
Evaluating efflux pump inhibition in Staphylococcus aureus 1199B strain using thiadiazine-derived compounds: In vitro and in silico approaches

使用噻二嗪衍生的化合物评估金黄色葡萄球菌1199B菌株的外排泵抑制作用: 体外和计算机方法

2024-12-010
PRE
MuDRA-Based Virtual Screening of Terpenes for Anti-Leishmania Infantum Activity: In Vitro Validation and Mechanistic Insights from Molecular Docking
2024-11-241
PRE
Thiazine-derived compounds in inhibiting efflux pump in Staphylococcus aureus K2068, mepA gene expression, and membrane permeability alteration

噻嗪衍生化合物抑制金黄色葡萄球菌K2068的外排泵,mepA基因表达和膜通透性改变

2024-10-010
OAAI
IBPA a mutual prodrug of ibuprofen and acetaminophen alleviates inflammation, immune dysregulation and fibrosis in preclinical models of systemic sclerosis
2024-07-010
PRE